Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

J Pollock, J Coffman, SV Ho… - Biotechnology progress, 2017 - Wiley Online Library
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …
被引用次数：178 相关文章

[引用][C] Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

J Pollock, J Coffman, SV Ho, SS Farid - Biotechnology Progress, 2017 - cir.nii.ac.jp
Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for
clinical and commercial antibody manufacture | CiNii Research CiNii 国立情報学研究所 学術情報 …

Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

J Pollock, J Coffman, SV Ho… - Biotechnology …, 2017 - pubmed.ncbi.nlm.nih.gov
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …
[HTML] nih.gov

[HTML][HTML] Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

J Pollock, J Coffman, SV Ho, SS Farid - Biotechnology Progress, 2017 - ncbi.nlm.nih.gov
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …

Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.

J Pollock, J Coffman, SV Ho… - Biotechnology …, 2017 - search.ebscohost.com
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …
[PDF] scienceopen.com

[PDF][PDF] Integrated Continuous Bioprocessing: Economic, Operational, and Environmental Feasibility for Clinical and Commercial Antibody Manufacture

J Pollock, J Coffman, SV Ho, SS Farid - scienceopen.com
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …

Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.

J Pollock, J Coffman, SV Ho, SS Farid - Biotechnology Progress, 2017 - europepmc.org
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …

Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

J Pollock, J Coffman, SV Ho, SS Farid - Biotechnology Progress, 2017 - discovery.ucl.ac.uk
This paper presents a systems approach to evaluating the potential of integrated continuous
bioprocessing for monoclonal antibody (mAb) manufacture across a product's lifecycle from …